Tuesday 19 September 2017

Recent Release: Angioedema Treatment Market 2017 to 2025 - Industry, Size, Share, Growth Prospects, Key, Opportunities, Trends and Forecast BY Acute Market Reports

Angioedema Treatment Market Growth, Future Prospects and Competitive Analysis, 2017-2025, the angioedema market was valued at USD 895.4 Mn in 2017, and is expected to reach USD 1,658.0 Mn by 2025, expanding at a CAGR of 9.2% from 2017 to 2025.


Market Insights
Growth in healthcare investments, prevalence of angioedema and growing high-risk geriatric population are the major factors driving the global market growth for angioedema treatment. North America is the largest regional market at a market share of over 41% in 2015, and the dominance of this region is anticipated to continue through 2022. Rising incidence of angioedema and high awareness about treatment and the management of angioedema together drive the North America angioedema market. Asia Pacific is expected to be the fastest growing market in the global angioedema market due to rising prevalence rate in the countries like Japan, China and others. Moreover, the growing research and development in the drug discovery of angioedema would further drive the market during the forecast period.


The treatment types include Antihistamines, Corticosteroids, Autoimmune drugs, antifibrinolytic agents and blood protein controllers. Antihistamines and Corticosteroids accounted for approximately 45% - 50% of the total market share because these are the first line therapies preferred by the medical practitioners and majorly used as supportive therapies and most accessible source of treatment across the globe. Despite the high cost of new treatment options in comparison to older therapies such as attenuated androgens and antifibrinolytic agents, they are popular with physicians due to the superior control offered over symptoms such as subcutaneous and abdominal swelling.
These highly priced drugs have therefore managed to capture a high prescription share. Hence, introduction of new drugs with further improved effectiveness and safety will drive the global angioedema market during the forecast period.


Table of Content :
Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Methodology
Chapter 2 Executive Summary
2.1 Global Angioedema Treatment Market Portaiture
2.2 Global Angioedema Treatment Market, by Treatment, 2015 (USD Mn)
2.3 Angioedema Treatment Market Share, by Geography, 2015 (Value %)
Chapter 3 Angioedema Treatment : Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.2 Rising Geriatric Population
3.3.1.3 Government Initiative
3.3.2 Challenges
3.3.2.1 Slow Responding Commercialization Of New & Effective Therapies
3.3.3 Opportunities
3.3.3.1 Technological Advancements
3.4 Attractive Investment Proposition
3.5 Competitive Analysis
3.5.1 Market Share Analysis By Key Players, 2015 (Value %)
Chapter 4 Global Angioedema Treatment Market, by Treatments
4.1 Preface
4.2 Antihistamines
4.1 Cortecosteroids
4.2 Autoimmune Drugs
4.1 Antifibrinolytic Agents
4.2 Blood Protein Controllers
Chapter 5 Global Angioedema Treatment Market, By Pipeline Treatment Analysis
4.3 Overview
4.3 Phase I
4.3 Phase II
4.3 Phase III

Latest Reports:

About – Acute Market Reports:
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.

Contact Us:
Name : Chris Paul
Designation : Global Sales Manager
Toll Free(US/CANADA): +1-855-455-8662

No comments:

Post a Comment